Daniel Starczynowski

Professor

Cincinnati Children's Hospital Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Daniel Starczynowski is a Professor at Cincinnati Children's Hospital Medical Center in the United States. His research focuses on hematologic malignancies, including the genetic and molecular mechanisms underlying acute myeloid leukemia and myelodysplastic syndromes. Recent articles highlight his work on chemotherapy resistance, innate immune pathways, and splicing regulatory dynamics in leukemia treatments.

Articles (8)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2020

Collaborators (4)

Stephen T. Oh

UNITED STATES

View details

Yuki Maemoto

Assistant Professor

JAPAN

View details

Yoshihiro Hayashi

Professor

Ritsumeikan University

JAPAN

View details

H. Leighton Grimes

Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Starczynowski

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Characterization of E1 enzyme dependencies in mutant-UBA1 human cells reveals UBA6 as a novel therapeutic target in VEXAS syndrome

Splicing regulatory dynamics for precision analysis and treatment of heterogenous leukemias

Chemotherapy resistance in acute myeloid leukemia is mediated by A20 suppression of spontaneous necroptosis

DDX41 haploinsufficiency causes inefficient hematopoiesis under stress and cooperates with p53 mutations to cause hematologic malignancy

In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasms

Mitochondrial Fragmentation Triggers Ineffective Hematopoiesis in Myelodysplastic Syndromes

Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS

Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs

Collaborators (4)

Stephen T. Oh

Yuki Maemoto

Yoshihiro Hayashi

H. Leighton Grimes

Make your next move.